A 24-week live online programme that builds applied AI capability, from core analytics to production deployment, with a one-day campus immersion at IIT Delhi.

Applied Digital's strong revenue pipeline and the new data center campus could help it exceed Wall Street's growth expectations. The stock is expensive right now, but it can justify its valuation ...

CoreWeave is Applied Digital’s anchor customer with $11B in contracted lease revenue across 400 MW of data center capacity. Applied Digital holds $2.6B in debt against $1.9B in cash and issued $2.35B ...

Shares of Applied Digital have witnessed some volatility of late, but that shouldn't alarm investors with a long investing horizon. Applied Digital is on track to generate solid lease revenue from its ...

Applied Digital (APLD) continues its buildout of data centers for artificial intelligence workloads, with the latest being Delta Forge 1, a 430 MW campus located in the southern U.S. "Delta Forge 1 ...

Northland Capital Markets analyst Mike Grondahl on Tuesday maintained an Outperform rating on Applied Digital with a $40 price target. In addition, Lake Street analyst Rob Brown reiterated a Buy ...

Applied Digital is in the right place at the right time as AI spending ramps up. Its ability to achieve projects on time and on budget may help it win over the trust of big tech companies. A single ...

Applied Digital Corp (NASDAQ: APLD) shares are trending on Monday. Here’s a look at what you need to know. What To Know: Applied Digital has shifted its primary focus from hosting Bitcoin mining ...

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting ...

Applied Systems, an insurance software company owned by investment firm Hellman & Friedman, filed a trade secrets action against Ardent Labs on Nov. 21 in Illinois Northern District Court. The ...

Facing skepticism from analysts about whether it has the resources to take its rare disease drug to market, Applied Therapeutics is laying off almost half of the biotech's workforce to conserve its ...